Aileron Therapeutics, Inc. IPO Research Information

Aileron Therapeutics, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Aileron Therapeutics, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Aileron Therapeutics, Inc.	ALRN - NASDAQ	$15.00-$17.00	$15.00	$13.75	3.75 million	6/29/2017
Underwriter(s): BofA Merrill Lynch, Jefferies
Co-Manager(s): William Blair, Canaccord Genuity
Industry: Health Care
Filing(s): Filed 2017-06-02 Terms Added 2017-06-19

Aileron Therapeutics, Inc. Quote & Chart - Click for current quote - ALRN

About Aileron Therapeutics, Inc. (adapted from Aileron Therapeutics, Inc. prospectus):
They are a clinical-stage biopharmaceutical company that is focused on developing and commercializing a novel class of therapeutics called stapled peptides.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "ALRN" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.